Alternative Payment Models provides insights on key innovative payment and care delivery models, along with biopharmaceutical company opportunities to engage in partnerships with participating organizations.
Which innovative payment models have the broadest adoption across payers and providers?
What are the most common risk arrangements for innovative payment models, and what services do these arrangements include?
Which CMS Innovation Center demonstrations are likely to have the greatest impact on payer and IDN business strategies and drug access decisions?
Use Alternative Payment Models to:
- Anticipate the impact of APMs on payer and IDN strategies and access decisions
- Evaluate the impact of emerging innovative models on biopharmaceutical company relationships with payers and providers
- Assess the impact of CMS Innovation Center models on payer and IDN behavior
-
Evolution of Alternative Payment Models
- Health plan and provider adoption of alternative payment models (APMs)
- Assessment of risk and success in innovative payment models
- Biopharmaceutical company opportunities to partner with customers that participate in APMs
-
Impact of CMS Innovation
- Identification of key CMS innovation models
- Uptake of CMS Innovation Center demonstrations among payers and integrated delivery networks (IDNs)
- Influence of demonstrations on the marketplace